MedAdNews (and me) on drug reimportation

It’s been a while since drug reimportation has been big news, and that’s not likely to change too soon according to a MedAdNews article (Importation debate on mute). I’m quoted extensively in the article, which you won’t be able to access unless you have a subscription. I mention that drug reimportation is taking a back seat to the debate on universal health care and that the rollout of Medicare Part D has also taken some of the urgency out of the debate. Wal-Mart has done its part, too with the $4 generics program. However, if universal care ever actually comes into existence (which I’m not counting on) we can expect to see drug reimportation come to the fore as a cost saving measure.

January 4, 2008

One thought on “MedAdNews (and me) on drug reimportation”

  1. Even if it comes back, one of the key issues to remember is that generics are less expensive in the US than (for example) Canada. For the same reason, lack of competition, generics are more expensive overseas.

    As our market has shifted from 40% generics to more than 60% generics over the past few years, I am not sure this issue will have the same urgency ever.

Leave a Reply

Your email address will not be published. Required fields are marked *